Patent Assignment
Reel/Frame 071877/0049
Assignment of Assignor's Interest
Recorded: 2025-07-30
Pages: 5
Assignor
ERASCA, INC.
Executed: 2025-04-10
Assignee
KATMAI PHARMACEUTICALS, INC.
1126 GOLDENROD AVENUE, CORONA DEL MAR, CALIFORNIA, 92625
Covered Property
(1)
POLYMORPHIC FORMS OF (S)-N-(3-BROMO-2-FLUOROPHENYL)-7-((4-METHYLPIPERAZIN-1-YL)METHYL)-7,8-DIHYDRO-[1,4]DIOXINO[2,3-g]QUINAZOLIN-4-AMINE AS EGFR INHIBITORS
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.